For cancer patients, treatment begins long before an infusion chair is occupied. Behind the scenes, community oncology practices must forecast demand, purchase costly specialty drugs, manage inventory, and navigate a maze of contracts, rebates and payer requirements.

At Oklahoma Cancer Specialists and Research Institute, those responsibilities had grown increasingly complex. Rising drug costs, shrinking reimbursement margins, and limited visibility into purchasing and inventory data were creating operational challenges for the independent oncology practice.